Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia clinical trial (NCT04972227). Contact the study team or your healthcare provider for specific answers.

Question 2

How does CY6463 compare to my current medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia clinical trial (NCT04972227). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the study involve in terms of visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia clinical trial (NCT04972227). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia clinical trial (NCT04972227). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia clinical trial (NCT04972227). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia clinical trial (NCT04972227). Contact the study team or your healthcare provider for specific answers.

What this study is about